
Today, we announced the appointment of Sam Jackson, MD, MBA, as Chief Medical Officer. Dr. Jackson brings expertise in innovative neuroscience trial design and experience advancing therapies through pivotal development and FDA approval. nervgen.com/nervgen-appoints… #SCI #RESTORE


















